Cellomatics BioSciences (www.cellomaticsbio.com) provide preclinical in vitro research platforms to support drug development programmes of Biotech and Pharmaceutical companies in; Oncology, Immuno-oncology, Immunological and Inflammatory disease, Respiratory, Autoimmune, Cardiovascular and Metabolic disease. Our expertise lies in providing a range of assays including immunoassays, cell based functional assays including but not limited to target validation & qualification, biomarker qualification, toxicity, cell proliferation, migration, invasion, angiogenesis, vascular permeability using either 2D or 3D cell culture models. We have a team of experienced and qualified scientists who can understand your needs and deliver innovative and practical solutions.